Across the recent three months, 9 analysts have shared their insights on Legend Biotech (NASDAQ:LEGN), expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. In the assessment of 12-month price targets, analysts unveil insights for Legend Biotech, presenting an average target of $77.67, a high estimate of $86.00, and a low estimate of $73.00. Marking an increase o…